ANAP SRL
ANAP reported total assets of €1.37m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of ANAP shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +52 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ANAP's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 101,354 € | ||||
| Equity | 764,687 € | ||||
| Cash | 46,377 € | ||||
| EBITDA | 134,809 € | ||||
| Total assets | €1.37m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
ANAP's financial analysis
- Solvency55.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ANAP
ANAP's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0841.881.410
- VAT number
- BE0841881410
- Peppol
- Registered · 0208:0841881410 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2011
- Registered office
- 9300 Aalst
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ANAP (SRL) has been based in Aalst since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 101,354 € and equity of 764,687 €; its revenue is not published. Its solvency stands at 55.9%, above the median of its sector (44.0%).
Companies similar to ANAP
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie D'Helecine Retail sale of pharmaceutical products Hélécine · balance sheet €1.22m
- Thomas Broos Retail sale of pharmaceutical products Herent · balance sheet €1.19m
- Pharmanaus Retail sale of pharmaceutical products Herve · balance sheet €1.18m
- Rozental & Herman Retail sale of pharmaceutical products Charleroi · balance sheet €1.05m
- Apotheek Schellekens - Lauwers Retail sale of pharmaceutical products Schelle · balance sheet €1.84m
- Mylle Pharma Retail sale of pharmaceutical products Anzegem · balance sheet 947,525 €
- APR.P.D. Retail sale of pharmaceutical products Hasselt · balance sheet €2.05m
- Varmaca Retail sale of pharmaceutical products Peer · balance sheet €2.03m
Frequently asked questions about ANAP
What is the revenue of ANAP?
ANAP files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ANAP?
In Belgium, the VAT number is the company number prefixed with BE: BE0841881410 for ANAP, if the company is VAT-registered. Its company number (CBE) is 0841.881.410.
Where is the registered office of ANAP?
According to the CBE register, the registered office of ANAP is in 9300 Aalst.
What is the equity of ANAP?
At the close of the 2025 financial year, the equity of ANAP amounts to 764,687 €, a solvency of 55.9% of total assets.
Who manages ANAP?
The register lists 1 active mandates at ANAP. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ANAP
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →